NTX-472

N/A

Report date: 2024/06/17 16:33:49

Base Information

Drug NameNTX-472
Drug Alias NameNTX-472
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionB-lymphocyte antigen CD20 modulatorsB-lymphocyte antigen CD19 modulatorsCluster of differentiation 47 modulators
TargetsB-lymphocyte antigen CD20B-lymphocyte antigen CD19Cluster of differentiation 47
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNutcracker Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNutcracker Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A